Shares of Itron, Inc. (NASDAQ:ITRI – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twelve research firms that are covering the company, MarketBeat reports. Four investment analysts have rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have issued a report on the stock in the last year is $118.64.
ITRI has been the topic of a number of research analyst reports. StockNews.com lowered shares of Itron from a “strong-buy” rating to a “buy” rating in a report on Friday, June 28th. JPMorgan Chase & Co. increased their price objective on Itron from $104.00 to $112.00 and gave the company a “neutral” rating in a report on Tuesday, July 16th. Robert W. Baird lifted their target price on Itron from $115.00 to $123.00 and gave the stock an “outperform” rating in a report on Friday, August 2nd. Piper Sandler increased their price target on shares of Itron from $109.00 to $110.00 and gave the stock a “neutral” rating in a report on Monday, July 22nd. Finally, Stephens restated an “equal weight” rating and set a $110.00 price objective on shares of Itron in a research note on Monday, August 5th.
Get Our Latest Research Report on Itron
Insiders Place Their Bets
Hedge Funds Weigh In On Itron
Several large investors have recently modified their holdings of ITRI. Trexquant Investment LP raised its holdings in Itron by 18.4% in the 4th quarter. Trexquant Investment LP now owns 67,973 shares of the scientific and technical instruments company’s stock valued at $5,133,000 after buying an additional 10,542 shares during the period. Los Angeles Capital Management LLC purchased a new position in shares of Itron during the first quarter worth $2,002,000. Commonwealth Equity Services LLC acquired a new stake in shares of Itron in the first quarter valued at $1,076,000. Jupiter Asset Management Ltd. purchased a new stake in shares of Itron in the 1st quarter valued at $2,029,000. Finally, Oppenheimer & Co. Inc. lifted its stake in Itron by 91.1% during the 4th quarter. Oppenheimer & Co. Inc. now owns 30,568 shares of the scientific and technical instruments company’s stock worth $2,308,000 after acquiring an additional 14,573 shares in the last quarter. Institutional investors and hedge funds own 96.19% of the company’s stock.
Itron Trading Up 0.8 %
Shares of NASDAQ ITRI opened at $107.22 on Tuesday. Itron has a twelve month low of $56.11 and a twelve month high of $113.07. The firm has a market cap of $4.92 billion, a PE ratio of 30.81, a price-to-earnings-growth ratio of 0.84 and a beta of 1.47. The business has a fifty day simple moving average of $100.85 and a two-hundred day simple moving average of $99.49. The company has a quick ratio of 2.61, a current ratio of 3.16 and a debt-to-equity ratio of 0.98.
Itron (NASDAQ:ITRI – Get Free Report) last released its quarterly earnings data on Thursday, August 1st. The scientific and technical instruments company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.96 by $0.25. The firm had revenue of $609.07 million for the quarter, compared to the consensus estimate of $599.25 million. Itron had a net margin of 7.98% and a return on equity of 16.42%. The company’s quarterly revenue was up 12.6% on a year-over-year basis. During the same period last year, the firm earned $0.65 earnings per share. Analysts expect that Itron will post 4.59 earnings per share for the current fiscal year.
About Itron
Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.
See Also
- Five stocks we like better than Itron
- What Does Downgrade Mean in Investing?
- Take Advantage of Village Farms Stock as Cannabis Market Evolves
- How to Buy Cheap Stocks Step by Step
- MarketBeat Week in Review – 9/16 – 9/20
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- Don’t Miss These 3 Retail Stocks for Fall Gains
Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.